AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for ULTRAGENYX PHARMACEUTICAL · Biopharma company

Filing 1st Quarter - Termination

1st Quarter (Jan 1 - Mar 31) 2026 · California · posted Apr 20, 2026

Lobbying activity 1

Health Issues

n/a termination report

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem